News
All NewsAAP NewsPNP Corner
Media
Cure ConnectionsExpert InterviewsInsightsMedcastPeer ExchangePeers & PerspectivesPodcastsSponsored VideosWebinars
Puzzler
Publications
Contemporary Pediatrics JournalSupplements And Featured Publications
More
CME/CE
Resources
HandoutsJob BoardSponsored
Conferences
Conference CoverageConference Listing
Partnerships
Editorial
Editorial Advisory BoardWriter’s GuidelinesReference GuidelinesMeet the Editors

Subscribe

  • News
  • Media
  • Puzzler
  • Publications
  • CME/CE
  • Resources
  • Conferences
  • Partnerships
  • Subscribe
  • Editorial
  • Allergy, Immunology, and ENT
    • Food Allergies
    • Animal Allergies
  • Cardiology
    • Cardiovascular Diseases
  • Dermatology
    • Atopic Dermatitis
    • Acne
  • Emergency Medicine
  • Endocrinology
    • Diabetes
  • Gastroenterology
    • Formula
    • Nutrition
    • Obesity
  • Genetic Testing
  • Infectious Diseases
    • COVID-19
    • Influenza
    • Antibiotic Resistance
    • Vaccination and Immunization
    • Bacterial Conjunctivitis
    • Pneumonia
    • Sexually Transmitted Diseases
    • Vaccines
  • Mental, Behavioral and Development Health
    • Anxiety
    • Autism
    • Developmental/Behavioral Disorders
    • Depression
    • Psychiatry
    • ADHD
    • Addiction
    • Antisocial Personality Disorder
  • Neurology
    • Concussion
    • Epilepsy
    • Headache
  • OB/GYN
    • Neonatal/Perinatology
  • Pain
  • Pharmacology
    • Drug Pipeline News
  • Practice Improvement
    • Telemedicine
  • Respiratory
    • Asthma
    • Cystic Fibrosis
  • Rheumatology
Advertisement

Erin D. Parker, MD

Advertisement

Articles by Erin D. Parker, MD

Inhaled corticosteroid alternatives for young children after Flovent withdrawal | Image Credit: © Pixel-Shot - © Pixel-Shot - stock.adobe.com.

Inhaled corticosteroid alternatives for young children after Flovent withdrawal

ByErin D. Parker, MD,Joseph M. Collaco, MD, PhD
April 2nd 2025

Flovent was discontinued in January 2024 due to the manufacturer electing to produce only an authorized generic version of the medication.

Advertisement

Latest Updated Articles



    Advertisement
    Advertisement

    Trending on Contemporary Pediatrics

    1

    Weekly review: CDC's updated website, roflumilast 0.3%, and more

    2

    Transforming teen obesity care: How integrated specialty pharmacy models expand GLP-1 access

    3

    George Rodgers, III, MD, discusses antithrombin III's rare blood-clotting disorder expanded label

    4

    Daniele De Luca, MD, discusses zelpultide alfa in neonates at high risk of bronchopulmonary dysplasia development

    • About Us
    • Advertise
    • Contact Us
    • Editorial
    • Job Board
    • Terms and Conditions
    • Privacy
    • Do Not Sell My Personal Information
    Contact Info

    259 Prospect Plains Rd, Bldg H
    Cranbury, NJ 08512

    609-716-7777

    Brand Logo

    © 2025 MJH Life Sciences®

    All rights reserved.

    Home
    About Us
    News
    Contact Us